How Long Does Kliofem Take To Work

Absorption Rate & Bioavailability of Kliofem

After oral administration, both active components are rapidly absorbed from the gastrointestinal tract.

• Norethisterone acetate is quickly deacetylated to norethisterone. Peak plasma concentrations (T_max) occur 1–2 hours after dosing. Absolute bioavailability is approximately 64% due to first‑pass metabolism.
• Estradiol reaches peak plasma levels within 4–8 hours. Bioavailability is low (~5%) because of extensive hepatic first‑pass metabolism, but the dose (2 mg) compensates to achieve therapeutic circulating levels.

Both hormones are highly protein‑bound: estradiol binds to sex hormone binding globulin (SHBG) and albumin (≈98%), while norethisterone is about 96% bound. Food does not significantly affect absorption; tablets can be taken with or without meals.

Onset of Action: When Do Menopausal Symptoms Improve?

Hot flushes and night sweats typically begin to subside within the first 2 to 4 weeks of daily use. The reduction in frequency and severity is progressive, with many women noticing a clear difference by the end of the first month.

For vaginal dryness and urogenital symptoms, improvement may take 4 to 8 weeks as oestrogen gradually restores epithelial thickness and lubrication.

Bone protection is a long‑term effect: while biochemical markers of bone turnover change within weeks, meaningful increases in bone mineral density (BMD) are measurable only after 12 to 24 months of continuous treatment.

Peak Concentration & Maximum Clinical Effect

The peak plasma concentration (C_max) of estradiol occurs 4–8 hours after dosing, while norethisterone peaks earlier. However, the maximum therapeutic effect on vasomotor symptoms is not reached immediately.

• For symptom relief, the greatest reduction in hot flush frequency and severity is seen after 3 months of continuous use. Studies show a 70–90% reduction in moderate‑to‑severe flushes by this time.
• For endometrial protection, the progestogen component exerts its effect from the first dose, but the full suppression of oestrogen‑induced proliferation is achieved within the first treatment cycle.
• Steady state for both hormones is reached after approximately 5–7 days of daily dosing, meaning blood levels stabilise and the drug’s effects become predictable.

Duration in Body: How Long Does One Dose Last?

The duration of action is determined by the elimination half‑life and the continuous dosing regimen.

• Estradiol half‑life: 13–20 hours. Because it is administered daily, levels remain relatively stable with minimal fluctuation.
• Norethisterone half‑life: 7–9 hours. Its shorter half‑life means it declines faster, but daily dosing maintains sufficient progestogenic activity to protect the endometrium.

Although individual doses produce hormone levels that decline within 24 hours, the continuous combined regimen ensures that the endometrium is constantly exposed to progestogen, which is key to preventing hyperplasia. The duration of clinical benefit (symptom control) lasts as long as the medication is taken; symptoms may return within weeks after discontinuation.

How Kliofem Enters the Body: From Ingestion to Circulation

After swallowing the tablet, the following steps occur:

1. Disintegration and dissolution in the stomach and small intestine.
2. Absorption across the intestinal wall into the portal vein.
3. First‑pass metabolism in the liver, where a portion of estradiol is converted to estrone and other metabolites, reducing its bioavailability.
4. Systemic circulation: Unmetabolised estradiol and norethisterone enter the bloodstream, where they bind to carrier proteins (SHBG, albumin).
5. Tissue distribution: The free fraction diffuses into target tissues (hypothalamus, bone, breast, uterus, vagina) and binds to hormone receptors.

The process from ingestion to detectable blood levels takes about 30–60 minutes, with peak levels achieved as described above.

How Long Does Kliofem Take to Leave the Body?

Once you stop taking Kliofem, the hormones are eliminated through metabolism and excretion.

• Elimination half‑life: Estradiol ~13–20 hours; norethisterone ~7–9 hours. After 5 half‑lives (≈2–4 days), more than 97% of the drug is cleared from the body.
• Complete clearance: Typically within 2–3 days after the last dose.
• Metabolic by‑products: Both hormones are metabolised in the liver and excreted primarily in urine (60% estradiol metabolites, ~50% norethisterone metabolites) and faeces.

Clinical implication: If side effects occur, they usually subside within a few days after stopping. However, the return of menopausal symptoms may also begin within a week or two of discontinuation.

Factors That Affect How Quickly Kliofem Works

Several individual factors can influence the onset and duration of Kliofem’s effects:

• Age and time since menopause: Women closer to menopause may experience faster symptom relief than those who are many years postmenopausal.
• Concomitant medications: CYP3A4 inducers (e.g., rifampicin, St John’s wort) can accelerate hormone metabolism, potentially reducing efficacy and delaying symptom improvement.
• Liver function: Impaired hepatic metabolism may increase hormone levels and prolong half‑life.
• Body weight and composition: Adipose tissue can store oestrogens, but clinical relevance is minor for oral therapy.
• Consistency of use: Missing doses disrupts steady state, delaying full benefit and increasing the likelihood of breakthrough bleeding.

Kliofem Timeline FAQs

Need Kliofem with Clear Timing Guidance?

Understanding when to expect relief helps you manage menopause symptoms effectively. Our UK‑registered doctors can prescribe Kliofem and provide personalised advice on dosing and follow‑up.

Secure Prescription & Next‑Day Delivery

MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | Ongoing support